Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects

Virology. 2001 Jan 20;279(2):459-70. doi: 10.1006/viro.2000.0697.

Abstract

Data from murine models of chronic viral infection suggest that CD4+ T-cell responses to viral pathogens are important in sustaining the number and/or function of CD8+ cytotoxic T-cell (CTL) effectors. In this study, we used cytokine flow cytometry (CFC), staining with HLA-A*0201-peptide tetramers, and peptide stimulation with epitopic peptides to study functional CD4+ and CD8+ T-cell responses to cytomegalovirus (CMV) in human subjects coinfected with CMV and the human immunodeficiency virus, type 1 (HIV-1). We show that strong CD4+ and CD8+ T-cell responses to CMV antigens are sustained over time in HIV-1-infected individuals. Those who maintain a strong CD4+ T-cell response to CMV are also likely to maintain higher frequencies of CD8+ T cells capable of binding to HLA-A*0201-CMV pp65 (A2-pp65) tetramers as well as responses to pp65 peptide stimulation with effector cytokine production. These data support the hypothesis that declines in frequencies of CD4+ T-cell responses to CMV are associated with an inability to sustain high levels of CMV-specific CD8+ T-cell responses in HIV-1-infected subjects. These declines may precede the onset of CMV-associated end organ disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Viral / blood
  • Antigens, Viral / pharmacology
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / immunology*
  • Chronic Disease
  • Cytomegalovirus / immunology
  • Cytomegalovirus Infections / complications
  • Cytomegalovirus Infections / immunology*
  • Female
  • Flow Cytometry
  • HIV Infections / complications
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1*
  • HLA-A Antigens / analysis
  • Humans
  • Lymphocyte Count
  • Male
  • Phosphoproteins / pharmacology
  • Prospective Studies
  • Viral Matrix Proteins / pharmacology

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • HLA-A Antigens
  • Phosphoproteins
  • Viral Matrix Proteins
  • cytomegalovirus matrix protein 65kDa